139 related articles for article (PubMed ID: 36317181)
1. Protocol for high-throughput screening of SARS-CoV-2 main protease inhibitors using a robust fluorescence polarization assay.
Zhang J; Yan H; Yan G; Liu X; Wang Y; Chen Y
STAR Protoc; 2022 Dec; 3(4):101794. PubMed ID: 36317181
[TBL] [Abstract][Full Text] [Related]
2. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
3. Protocol to identify flavonoid antagonists of the SARS-CoV-2 main protease.
Yang M; Lin L; Flaumenhaft R
STAR Protoc; 2024 Jun; 5(2):102990. PubMed ID: 38583157
[TBL] [Abstract][Full Text] [Related]
4. Improved fluorescence-based assay for rapid screening and evaluation of SARS-CoV-2 main protease inhibitors.
Zhang R; Yan H; Zhou J; Yan G; Liu X; Shang C; Chen Y
J Med Virol; 2024 Mar; 96(3):e29498. PubMed ID: 38436148
[TBL] [Abstract][Full Text] [Related]
5. Invalidation of geraniin as a potential inhibitor against SARS-CoV-2 main protease.
Zhang R; Yan H; Zhou J; Liu X; Chen Y
Nat Prod Res; 2024 Jun; 38(12):2078-2081. PubMed ID: 37533400
[TBL] [Abstract][Full Text] [Related]
6. Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors.
Yan G; Li D; Lin Y; Fu Z; Qi H; Liu X; Zhang J; Si S; Chen Y
Cell Biosci; 2021 Dec; 11(1):199. PubMed ID: 34865653
[TBL] [Abstract][Full Text] [Related]
7. [Identifying SARS-CoV-2 main protease inhibitors by a novel sandwich-like fluorescence polarization screening assay].
Yan H; Yan G; Qi H; Liu Z; Liu X; Liu X; Li N; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2352-2364. PubMed ID: 35786485
[TBL] [Abstract][Full Text] [Related]
8. Biochemical screening for SARS-CoV-2 main protease inhibitors.
Coelho C; Gallo G; Campos CB; Hardy L; Würtele M
PLoS One; 2020; 15(10):e0240079. PubMed ID: 33022015
[TBL] [Abstract][Full Text] [Related]
9. [Discovery of SARS-CoV-2 main protease inhibitors using an optimized FRET-based high-throughput screening assay].
Yan G; Li D; Qi H; Fu Z; Liu X; Zhang J; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2236-2249. PubMed ID: 35786475
[TBL] [Abstract][Full Text] [Related]
10. A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors.
Yan H; Liu Z; Yan G; Liu X; Liu X; Wang Y; Chen Y
Virology; 2022 Sep; 574():18-24. PubMed ID: 35870326
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M
Malla TR; Tumber A; John T; Brewitz L; Strain-Damerell C; Owen CD; Lukacik P; Chan HTH; Maheswaran P; Salah E; Duarte F; Yang H; Rao Z; Walsh MA; Schofield CJ
Chem Commun (Camb); 2021 Feb; 57(12):1430-1433. PubMed ID: 33462575
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.
Jiménez-Alberto A; Ribas-Aparicio RM; Aparicio-Ozores G; Castelán-Vega JA
Comput Biol Chem; 2020 Oct; 88():107325. PubMed ID: 32623357
[TBL] [Abstract][Full Text] [Related]
13. A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease.
Baker JD; Uhrich RL; Kraemer GC; Love JE; Kraemer BC
PLoS One; 2021; 16(2):e0245962. PubMed ID: 33524017
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput Fluorescent Assay for Inhibitor Screening of Proteases from RNA Viruses.
Cihlova B; Huskova A; Böserle J; Nencka R; Boura E; Silhan J
Molecules; 2021 Jun; 26(13):. PubMed ID: 34206406
[TBL] [Abstract][Full Text] [Related]
15. Developing evolution-resistant drugs for COVID-19.
Weinreich DM
Elife; 2022 Jul; 11():. PubMed ID: 35880850
[TBL] [Abstract][Full Text] [Related]
16. Luminescent Assay for the Screening of SARS-CoV-2 M
Sondag D; Merx J; Rossing E; Boltje TJ; Löwik DWPM; Nelissen FHT; van Geffen M; van 't Veer C; van Heerde WL; Rutjes FPJT
Chembiochem; 2022 Aug; 23(15):e202200190. PubMed ID: 35649961
[TBL] [Abstract][Full Text] [Related]
17. In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease.
Cheng AJT; Macalino SJY; Billones JB; Balolong MP; Murao LAE; Carrillo MCO
J Mol Model; 2022 Oct; 28(11):345. PubMed ID: 36205801
[TBL] [Abstract][Full Text] [Related]
18. Fluorogenic
Ihssen J; Faccio G; Yao C; Sirec T; Spitz U
STAR Protoc; 2021 Sep; 2(3):100793. PubMed ID: 34423318
[TBL] [Abstract][Full Text] [Related]
19. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
Cetin A
Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
Goyal B; Goyal D
ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
